This study was conducted to determine the effects of intravenous detomidine on Schirmer tear test (STT) results in clinically normal horses. Eighteen adult horses were randomly divided into two groups of nine horses each. The treatment group was sedated with intravenous detomidine alone (20 mg/kg), and the control group received only intravenous saline (0.2 mL/100 kg). Schirmer tear test was performed just before intravenous administration of detomidine or saline in treatment and control groups, respectively. Schirmer tear tests were repeated 5, 20, 60, and 120 minutes later. Horses enrolled in this study consisted of nine males and nine females. Breeds were Arabian and Hanoverian, ranging from 3 to 6 years in age. In the treatment group, the pretreatment and subsequent posttreatment mean AE standard deviation values were 17.0 AE 6.9 (0 minutes), 11.8 AE 2.9 (5 minutes), 12.1 AE 2.0 (20 minutes), 12.1 AE 3.1 (60 minutes), and 15.0 AE 2.8 (120 minutes) mm wetting/min. In this group of horses, a significant reduction was observed in STT values at 5, 20, and 60 minutes after treatment with detomidine hydrochloride in comparison to the pretreatment values (analysis of variance with post hoc testing; P 5 ¼ 0.004, P 20 ¼ 0.007, P 60 ¼ 0.006). There was no significant difference between baseline values and posttreatment values in the control saline group (P ! .08). We conclude that intravenous detomidine causes a significant reduction in STT values in clinically normal horses. In horses, practitioners should measure STT values before intravenous administration of detomidine to accurately assess the results.
Introduction
Complete ophthalmic examination in the horse generally requires sedation [1] . Standing sedation greatly facilitates a proper ophthalmic examination, many ocular procedures of the horse, and enhances safety to both the equine patient and examiner [2] . In horses, alpha-2-adrenoceptor agonists such as xylazine and detomidine are commonly used sedatives for a thorough ocular examination [1] . Tranquilization with detomidine hydrochloride is often preferred for ophthalmic examination in horses because it provides rapid tranquilization without an excitation phase and a steady head position without movement (such as the head "jerks" commonly associated with xylazine or butorphanol tartrate tranquilization) [3] .
It is important to consider the possible effects of sedatives such as detomidine on the results of ocular examination diagnostic tests. The effect of several sedatives on Schirmer tear test (STT) results has been investigated in dogs, cats, and rabbits [4] [5] [6] [7] . Remarkably, little is known about the effects of sedatives on STT results in horses. Results of one study indicated that sedation with xylazine does not affect the STT values in horse [8] . A literature search found no published work on the effects of detomidine on tear secretion in horses. The aim of the present investigation was to identify any effects of intravenous administration of detomidine on STT results in clinically normal horses.
Materials and Methods
Eighteen healthy adult horses without ocular abnormalities were included in this study. Before the study, the normal status of the horses was verified by results of general physical and ophthalmic examinations (STT I, slit lamp biomicroscopy, indirect ophthalmoscopy) as well as results of a complete blood count.
The eighteen horses were randomly assigned to a treatment or control group. Horses in the treatment group (n ¼ 9) received intravenous detomidine hydrochloride (20 mg/kg, Cepesedan RP, CP-Pharma GmbH, Germany), and horses in the control group (n ¼ 9) received intravenous saline (0.2 mL/100 kg, Tehran Chemie, Iran). Baseline STT values were recorded just before intravenous administration of detomidine or saline in treatment and control groups, respectively. Schirmer tear test was performed by inserting STT strip inside the lower eyelid approximately one third the distance from the temporal to nasal canthus for 60 seconds (Biotech Vision Care, Leicester, UK, Lot number: SC0712801). Schirmer tear tests were then repeated 5, 20, 60, and 120 minutes later.
Statistical Analysis
The results were analyzed by using the software package SPSS 16.0 for Windows. Data were expressed as mean AE standard deviation (SD). One-sample KolmogorovSmirnov test was used to evaluate whether the data were normally distributed. Schirmer tear test values between right and left eyes were compared with paired samples ttest. Then, the data for both eyes were averaged for further analysis. One-way repeated measures analysis of variance (ANOVA) with post hoc testing was used to compare data within the same group and to assess differences between groups. P < .05 was considered statistically significant.
Results
The study population was comprised of 18 sexually intact horses (nine females and nine males) ranging from 3 to 6 years of age. The breeds were Arabian and Hanoverian. Mean AE SD body weight was 393.8 AE 79.6 kg. The results of the measurements of STT are shown in Fig. 1 . The data were expressed in units of based on mm/min. All data were normally distributed (one-sample Kolmogorov-Smirnov test; P ! .3).
There were no statistically significant differences between the pretreatment STT mean values for the right and left eyes in both treatment and control groups (P values, respectively, included .65 and .94).
A mean STT was calculated for each horse using the measuring value from the left eye and the right eye at each time point. The mean AE SD baseline STT values for treatment and control groups were 17.0 AE 6.9 and 18.1 AE 3.1 mm wetting/min, respectively. For baseline STT values, there was no significant difference between treatment and control groups (ANOVA with post hoc testing; P 0 ¼ 0.53).
In the treatment group, the subsequent posttreatment mean AE SD values were 11.8 AE 2.9 (5 minutes), 12.1 AE 2.0 (20 minutes), 12.1 AE 3.1 (60 minutes), and 15.0 AE 2.8 (120 minutes) mm wetting/min. In this group of horses, a significant reduction was observed in STT values at 5, 20, and 60 minutes after treatment with detomidine hydrochloride in comparison to the baseline values (ANOVA with post hoc testing; P 5 ¼ 0.004, P 20 ¼ 0.007, P 60 ¼ 0.006, P 120 ¼ 0.26).
In the control group, the mean AE SD STT values at 5, 20, 60, and 120 minutes were 18.2 AE 3.9, 18.5 AE 4.7, 19.3 AE 2.5, and 21.2 AE 2.5 mm wetting/min respectively. There was no significant difference between baseline values and posttreatment values in control group (P ! .08).
Statistical comparisons between posttreatment values of treatment and control groups indicated significant differences at 5 minutes (P 5 ¼ 0.001), 20 minutes (P 20 ¼ 0.001), 60 minutes (P 60 < 0.001), and 120 minutes (P 120 ¼ 0.001).
Discussion
Detomidine was chosen in this study because it is an effective sedative commonly used for ophthalmic examinations in horses [3] . To our knowledge, the present study is the first detailed documentation of STT changes after intravenous injection of detomidine in horses. During the pretreatment period, the baseline STT values for all horses were established to be within the reference range reported in normal horses. The results of STT 1 in normal horses vary widely, and mean values from 12.7 mm wetting/1 min to 24.8 mm wetting/min are reported [9, 10] .
The results of the present study indicate that intravenous detomidine at the dosage of 20 mg/kg results in a statistically significant decrease in STT values in this group of horses. In the study reported here, a significant decrease in STT values was evident 5 minutes after intravenous administration of detomidine and was maintained up to 1 hour after treatment. Based on our findings, the peak reduction in STTs was observed at 5 minutes after intravenous administration of detomidine. At this measurement point, STT values decreased by an average of 5.2 mm wetting/min or 30% in comparison to the baseline value. Our findings are in agreement with those of similar studies in that significant STT reduction has been observed after the administration of alpha-2-adrenorecptor agonists such as medetomidine in dogs and xylazine in cats [5, 6] .
The exact mode of action of detomidine in decreasing lacrimation in horses is unclear. However, several possible reasons have been described by investigators who studied the effects of sedatives on STT results in dogs. The suggested mechanisms included the following: central effects of these drugs on autonomic regulation of tear production, effective antinociception, vasoconstriction of the tear gland itself, and altered metabolism at the glands cellular level [4] .
Detomidine is an alpha-2-adrenorecptor agonists that produces sedation, analgesia, and muscle relaxation which are comparable to those produced by xylazine in intensity but last longer. The onset of sedation, analgesia, and muscle relaxation is rapid after intravenous or intramuscular administration of detomidine. In the horse, peak sedation and analgesia are achieved within 15 minutes after intravenous administration of detomidine at a dose of 20 mg/kg and persist for approximately 1 hour [9, 11] .
This information helps to explain our results in which the tear reduction was observed within 5 minutes after intravenous administration of detomidine and persist until 60 minutes after drug injection in the horses of the treatment group. The reduction of STT in the treatment group is most likely reflects a direct effect of detomidine because comparisons between posttreatment values of treatment and control groups indicated that STTs in treatment group at 5 minutes, 20 minutes, 60 minutes, and 120 minutes were significantly lower than obtained values horses of control group. The control horses were considered in this study to evaluate the effect of time as variable on STT results.
Tears have an important role in maintaining corneal and conjunctival health [12] . Therefore, accurate measurement of STT values is important indicator of corneal health and diseases state. In the present study, all measurements were performed by one examiner and STT values obtained by using a 5 mm Â 35 mm schirmer tear strips of the same manufacture and lot number, and special attention was given to place the STT strips inside the lower eyelid approximately one third the distance from the temporal to nasal canthus.
The STT is the test most commonly used to measure aqueous tear production in veterinary species. The STT results can vary due to the absorptive capacity of different brands of filter paper, improper placement of the paper, and experience of the person performing the STT [13] [14] [15] .
In summary, the intravenous administration of detomidine appears to result in a temporary but significant reduction in STT values in clinically normal horses. In horses, practitioners should measure STT values before intravenous administration of detomidine to accurately assess the results.
